Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense

Clinical trial NCT03974178 · COMPLETED

Trial details

NCT number: NCT03974178
Sponsor: Drugs for Neglected Diseases
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Trypanosomiasis, African Sleeping Sickness Trypanosoma Brucei Rhodesiense; Infection

Start date: 2019-09-29
Primary completion: 2021-11-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.